Evidence map›Paper›PMID 31074489›Full record

ArticleThe Journal of antimicrobial chemotherapy2019

'Antibiotic footprint' as a communication tool to aid reduction of antibiotic consumption.

Direk Limmathurotsakul, Jonathan A T Sandoe, David C Barrett, Michael Corley, Li Yang Hsu, Marc Mendelson, Peter Collignon, Ramanan Laxminarayan, Sharon J Peacock, Philip Howard

Abstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Adopting a Global AMR Target within the Pandemic Instrument Will Act as a Catalyst for Action.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2022
    Article
  10. Article
  11. Article
  12. Antimicrobial peptide polymers: no escape to ESKAPE pathogens-a review.World journal of microbiology & biotechnology · 2020
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Direk LimmathurotsakulMahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand.
Jonathan A T SandoeUniversity of Leeds/Leeds Teaching Hospitals NHS Trust, Leeds LS1 3EX, UK.
David C BarrettBristol Veterinary School, University of Bristol, Bristol BS40 5DU, UK.
Michael CorleyBritish Society of Antimicrobial Chemotherapy, Birmingham B1 3NJ, UK.
Li Yang HsuSaw Swee Hock School of Public Health, National University of Singapore and National University Health System, 12 Science Drive 2, Singapore 117649, Singapore.
Marc MendelsonDivision of Infectious Diseases & HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, 7925, South Africa.
Peter CollignonInfectious Diseases and Microbiology, Canberra Hospital, Canberra, 2605, Australia.
Ramanan LaxminarayanCenter for Disease Dynamics, Economics & Policy, New Delhi, 110024, India.
Sharon J PeacockDepartment of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Philip HowardUniversity of Leeds/Leeds Teaching Hospitals NHS Trust, Leeds LS1 3EX, UK.

Funding

Wellcome Trust
6 · The paper itself

Abstract

'Superbugs', bacteria that have become resistant to antibiotics, have been in numerous media headlines, raising awareness of antibiotic resistance and leading to multiple action plans from policymakers worldwide. However, many commonly used terms, such as 'the war against superbugs', risk misleading people to request 'new' or 'stronger' antibiotics from their doctors, veterinary surgeons or pharmacists, rather than addressing a fundamental issue: the misuse and overuse of antibiotics in humans and animals. Simple measures of antibiotic consumption are needed for mass communication. In this article, we describe the concept of the 'antibiotic footprint' as a tool to communicate to the public the magnitude of antibiotic use in humans, animals and industry, and how it could support the reduction of overuse and misuse of antibiotics worldwide. We propose that people need to make appropriate changes in behaviour that reduce their direct and indirect consumption of antibiotics.

Indexed as

Drug Resistance, MicrobialHealth CommunicationHealth Knowledge, Attitudes, PracticeAnimalsAnti-Bacterial AgentsAntimicrobial StewardshipBacteriaGlobal HealthHumansPharmacistsPrescription Drug OverusePublic HealthAnti-Bacterial Agents

Identifiers

PMID31074489
PMCPMC6640305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.